CMS Clarifies Patient Financial Responsibility for COVID-19 Testing

When the first guidance on COVID-19 testing was released on March 13, CMS made it clear that there would be no beneficiary cost obligations for the COVID-19 test. This, though, was simply a basic tenet of the Medicare payment system; there is never beneficiary coinsurance or deductibles on approved lab tests.